title: Hypertrigyceridemia during infliximab therapy.
authors.affiliation: University Hospital of Nancy, Regional Pharmacovigilance Center, 54035 Nancy, France. Electronic address: l.javot@chu-nancy.fr.
authors.forename: Lucie
authors.initials: L
authors.lastname: Javot
authors.affiliation: University Hospital of Nancy, Department of Rheumatology, 54511 Vandœuvre-les-Nancy, France.
authors.forename: Patrice
authors.initials: P
authors.lastname: Pere
authors.affiliation: University Hospital of Nancy, Department of Diabetology, Metabolic Diseases and Nutrition, 54511 Vandœuvre-les-Nancy, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Got
authors.affiliation: University Hospital of Nancy, Regional Pharmacovigilance Center, 54035 Nancy, France.
authors.forename: Nadine
authors.initials: N
authors.lastname: Petitpain
authors.affiliation: University Hospital of Nancy, Department of Hepatogastroenterology, 54511 Vandœuvre-les-Nancy, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Peyrin-Biroulet
authors.affiliation: University Hospital of Nancy, Regional Pharmacovigilance Center, 54035 Nancy, France; University Hospital of Nancy, Department of Pharmacology and Toxicology, 54035 Nancy, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Gillet
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001168:Arthritis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D000069285:Infliximab; D008297:Male; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab
keywords: Anti-TNF; Biotherapy; Hypertriglyceridemia